Chiesi Pharmaceutical Group - Carbon Neutrality Service - Climate Bridge (Shanghai) Ltd. Copyright.

EN - CN

Home
Services

Services

Carbon Credit Management

Carbon Credit Trading

Renewable Energy Certificates

Sustainable Development Consulting

With a wealth of of experience in the development of carbon credit projects, Climate Bridge can provide project owners with carbon credit development services related to ecological carbon sinks, methane utilization, renewable energy and others. Types of projects we develop include:

Ecological Carbon Sinks
Methane Utilization
Renewable Energy
Others

Details

We have different types of carbon credit resources that can help companies neutralize the GHGs emissions they produced and help to achieve their carbon neutrality goals. The carbon credits we offer include:

Carbon Removal Project
Carbon Avoidance Project

Details

With international renewable energy certificate trading, we can assist companies achieve clean power procurement and reduce greenhouse gas emissions. The renewable energy certificate services we offer include:

Registration and Issuance
Trading

Details

Climate Bridge provides consulting services to assist companies improving sustainable development performance and enhance their ability to address climate change. The consulting services we offer include:

Carbon Neutrality Consulting
Product Carbon Footprint Consulting
Carbon Emission Management Consulting
Carbon Finance Management Consulting
Sustainable Development Disclosure Consulting

Details
Cases

Cases

Carbon Credit Development

Carbon Neutrality Service

Details

Details
Media Room

Media Room

News

Disseminate relevant developments in the fields of carbon asset development, carbon neutral solutions, training services, knowledge popularization, etc., contributing to global sustainable development in a sustained manner.

Details
About Us

About Us

About Us

Founded in 2006, Climate Bridge is one of the earliest enterprises engaged in carbon assets development and carbon neutrality solutions in China, and is one of the most active developers and traders in the domestic and international carbon trading markets.

Details
Contact Us

Contact Us

Contact Us

With a strong and experienced team, Climate Bridge is one of the earliest industry leaders in China to engage in carbon emission reduction project development and carbon neutral solution consulting. We provide project owners with carbon emission reduction project development management and carbon credit trading services, as well as a wide range of carbon credit products and carbon neutral services for organizations and individuals contributing to climate change.

Details

Chiesi Pharmaceutical (Shanghai)

Description

About Chiesi Pharmaceutical Group

Founded in 1935, the Chiesi Group is an international company based in Parma, with a strong focus on research, development, production and the commercialisation of innovative medicines in the Respiratory, Neonatology, Rare Disease and Special Care Therapeutic Areas.

In 2008, Chiesi Pharmaceutical (Shanghai) Co., Ltd, a wholly owned subsidiary of Chiesi Group in China, was established to take full responsibility for Chiesi Group's product registration, promotion and sales services and opened a new chapter of Chiesi Group's direct operations in Chinese market.

In 2021, Chiesi Group launched its B Corp re-certification with the Eco-Friendly Products Challenge initiative, while making further progress on its carbon minimal pressurised Metered Dose Inhaler (pMDI) Program, which aims to reduce the carbon footprint of its inhalers by up to 90%. In 2021, Chiesi joined the B Corp Climate Collective (BCCC), committing to the United Nations Framework Convention on Climate Change (UNFCCC) “Race To Zero”.

Service Content

As one of the main developers and suppliers of green power certificates in China, Climate Bridge has helped Chiesi Pharmaceutical (Shanghai) Co., Ltd achieve its goal of net-zero Scope 2 (electricity) emissions for its Shanghai facility by providing the International Renewable Energy Certificates (I-REC).